Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2021-07-30 Investor Presentation
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2021' and is dated July 30, 2021. It contains detailed financial data for Q1 FY22, including revenue, EBITDA, PAT, and EPS, along with management commentary and strategic outlook. The document is a presentation intended for analysts and investors, focusing on quarterly financial results and business highlights. It is not a full quarterly report with comprehensive financial statements but rather a presentation summarizing earnings and operational highlights. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and content confirm it is the presentation itself, not just an announcement or a certification.
2021-07-30 English
Record Date
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors regarding the approval of unaudited financial results for the quarter ended June 30, 2021. It includes a Limited Review Report by the statutory auditors Deloitte Haskins & Sells LLP, which is a standard practice for interim financial results. The document contains consolidated unaudited financial results with detailed financial data for the quarter, including income, expenses, and tax details. The presence of the auditor's review report and the detailed financial statements indicates this is an interim financial report. The document also mentions the declaration of an interim dividend, but the primary content is the financial results and auditor's review for the quarter. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-07-30 English
Dividend
Regulatory Filings
2021-07-30 English
Financial Result Updates
Regulatory Filings
2021-07-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed Scrutinizer's Report and Voting Results of the 27th Annual General Meeting (AGM) of Dr. Lal PathLabs Limited held on July 29, 2021. It includes voting results on various resolutions such as adoption of audited financial statements, dividend declaration, director re-appointment, and remuneration approvals. The report is pursuant to Section 108 of the Companies Act, 2013 and related rules, and it provides consolidated voting outcomes from remote e-voting and e-voting during the AGM. The content is focused on the official results of shareholder votes at the AGM, not the AGM presentation materials themselves or the full annual report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, confirming it is not a mere announcement or a short notice but a full voting results report.
2021-07-29 English
Shareholders meeting
Regulatory Filings
2021-07-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.